By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

BioMarin Pharmaceutical Inc. 

105 Digital Drive

Novato  California  94949  U.S.A.
Phone: 415-506-6700 Fax: 415-382-7427


SEARCH JOBS


Industry
Biotechnology






Company News
BioMarin Pharmaceutical Inc. (BMRN) Sells Priority Review Voucher For $67.5 Million 7/30/2014 3:51:46 PM
Sarah Cannon Research Institute UK And BioMarin Pharmaceutical Inc. (BMRN) Collaborate On EMBRACA Clinical Study In Hereditary Breast Cancer With BRCA Mutation 7/23/2014 12:53:41 PM
BioMarin Pharmaceutical Inc. (BMRN) To Host Second Quarter 2014 Financial Results Conference Call And Webcast On Wednesday, July 30 At 4:30pm ET 7/9/2014 10:38:14 AM
BioMarin Pharmaceutical Inc. (BMRN) Announces Health Canada Approval Of VIMIZIMâ„¢ (elosulfase alfa) For The Treatment Of Morquio A Syndrome 7/7/2014 9:00:24 AM
BioMarin Pharmaceutical Inc. (BMRN) To Present At The Wells Fargo Healthcare Conference On June 17th 6/10/2014 9:53:27 AM
BioMarin Pharmaceutical Inc. (BMRN) Doses First Patient In Phase 3 INSPIRE Trial With BMN 701 For The Treatment Of Pompe Disease 5/27/2014 9:05:37 AM
BioMarin Pharmaceutical Inc. (BMRN) To Present At The Bank of America (BAC) Merrill Lynch 2014 Healthcare Conference On May 14th And The UBS Global Healthcare Conference On May 20th 5/6/2014 9:49:10 AM
Rare Disease Drugmaker BioMarin Pharmaceutical Inc. (BMRN) To Create 50 New Jobs In Ireland 5/2/2014 6:49:35 AM
BioMarin Pharmaceutical Inc. (BMRN) Announces First Quarter 2014 Financial Results And VIMIZIM™ Launch Progress 5/1/2014 4:17:09 PM
BioMarin Pharmaceutical Inc. (BMRN) Announces European Commission Approval For VIMIZIM® (Elosulfase Alfa) For The Treatment Of Morquio A Syndrome In Patients Of All Ages 4/28/2014 11:05:47 AM
12345678910...
//-->